ACM
NVAX icon

Aster Capital Management’s Novavax NVAX Stock Holding History

Aster Capital Management’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$38 Buy
+4
New +$36 ﹤0.01% 808
2026
Q1 		– Sell
-505
Closed -$3.39K – 1181
2025
Q4 		$3.39K Buy
+505
New +$3.81K ﹤0.01% 920
2025
Q2 		– Sell
-7,782
Closed -$64.8K – 1410
2025
Q1 		$64.8K Buy
7,782
+7,517
+2,837% +$62.1K 0.01% 743
2024
Q4 		$2.13K Buy
+265
New +$2.56K ﹤0.01% 967

Other funds holding NVAX

SCM
Shah Capital Management Raleigh, North Carolina $526M AUM 46.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return

Aster Capital Management's NVAX Position: Q2 2026 in Review

Aster Capital Management opened a new position in Novavax (NVAX) in Q2 2026: 4 shares worth $38. The stake represents ﹤0.01% of the portfolio and ranks #808 among its holdings. This is a return to the name: Aster Capital Management previously reported a position in NVAX as recently as Q4 2025.

Aster Capital Management first reported a position in NVAX in Q4 2024 and has held it in 4 quarters since. The position peaked at $64.8K in Q1 2025. 266 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.

  • Aster Capital Management held 4 shares of Novavax worth $38 as of Q2 2026.
  • Novavax was a new Aster Capital Management position in Q2 2026.
  • Novavax made up ﹤0.01% of Aster Capital Management's portfolio in Q2 2026, its #808 holding.
  • Aster Capital Management first reported a position in Novavax in Q4 2024 and has held it in 4 quarters since.
  • Aster Capital Management's Novavax position peaked at $64.8K in Q1 2025.
  • 266 funds tracked by Wall St. Rank held Novavax as of Q2 2026.

Based on Aster Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.